This comes as no surprise to many of us who have been filing cases against GlaxoSmithKline. Avandia was once the best selling diabetes drug in the world. In 2006, fueled by a mega-million dollar marketing campaign, Avandia sales hit $3.2 billion dollars a year. Soon after hitting blockbuster sales records, reports by the Cleveland Clinic suggesting the drug increased the risk of heart attacks, strokes, and other cardiovascular problems caused the FDA to issue a warning. That warning, along with further negative studies, caused a precipitous drop in sales for Avandia. Unfortunately, hundreds of thousands of diabetics continued to take Avandia.
It gets worse. For several years the US Senate has worked on a bipartisan investigation into Avandia and increased heart attack, stroke and other cardiovascular risks. The report from the investigation is highly critical of GlaxoSmithKline. Indeed, the report says that Glaxo failed to warn patients that Avandia could kill them! Further, the report goes on to say that Glaxo executives "attempted to intimidate independent physicians, focused on strategies to minimize or misrepresent findings that Avandia may increase cardiovascular risk, and sought ways to downplay findings that a competing drug [Actos] might reduce cardiovascular risk."
If you are one of the hundreds of thousands of diabetics still taking Avandia, consider talking to your physician and ask about Actos. You just might save your life.
Avandia Roundup: Sales Drop, GlaxoSmithKline Cut Jobs Washington, DC: A diabetes drug known to contribute to heart complications, fluid retention and weight gain continues to fall from its once-lofty perch. Avandia was at one time a giant in the treatment of Type 2 diabetes, but has fallen on hard times as more and more physicians move their patients away from Avandia, to alternative diabetes drugs that carry less risk.
Avandia Experiment may have Killed Mom Memphis, TN: When Sharon's mom first started taking Avandia for her diabetes, the drug was still experimental. Now, Sharon's mom is dead from congestive heart failure and Sharon herself is worried, after having taken Avandia for more than a year for her own diabetes.
Medical groups advise against using GlaxoSmithKlines Avandia --> Medical groups advise against using GlaxoSmithKline?s Avandia Public Citizen petitions the FDA to ban the diabetes drug Related Pages: Avandia GlaxoSmithKline plc Heart attack Acute Liver Failure (Fulminant Hepatitis) In October 2008, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes announced that members of a medical panel unanimously advised against using GlaxoSmithKline?s controversial diabetes drug, Avandia...
Is Avandia Worth the Risk Washington, DC: The alleged relationship between Avandia and heart attack remains a concern for Type 2 diabetes patients who, while pleased with Avandia's capacity for controlling their diabetes symptoms are nonetheless worried about various side effects associated with Avandia.
Avandia One Year Later Atlanta, GA: A new report suggests that doctors are continuing to be increasingly concerned with regard to the safety and efficacy of Avandia, with that concern increasing nine-fold since the once-popular GlaxoSmithKline diabetes drug blasted into the headlines last spring.
Diabetes Drug Avandia May Cause Bone Fractures New research shows that the popular diabetes drug Avandia may cause bone thinning, which could lead to osteoporosis and bone fractures. Although GlaxoSmith-Kline has admitted that women who take Avandia have a higher risk of bone fractures, this most recent study is the first one to explain the connection between bone fractures and the drug...